Literature DB >> 26793454

Unusual cause of recurrent fever after travel in South America.

B B Booth1, E Petersen1.   

Abstract

Fever in returning travelers is a common problem and usually the diagnosis is made within a few days or the traveler recovers. We present two travelers who presented with fever two weeks after returning from a six week vacation in South America. Over the following 18 months they presented with short attacks of fever, elevated CRP and leukocytosis and the program for investigation became more and more elaborate. A curious and key feature was, that they were completely synchronous both developing symptoms within an hour and presentation with the same laboratory findings of leukocytosis and elevated CRP. Extensive and repeated tests were performed, at our facility and abroad. After a year it was discovered that the uses of aroma oils were associated with the symptoms. No similar case has been found to be reported previously. These cases emphasize that natural products are not inherently safe. The investigational program was build up over time as new attacks continued to occur and suggestions from different centers which were consulted were followed up. The number of tests performed at different laboratories took an extensive amount of time. These cases emphasize that a panel of analysis in returning travelers in which no clear diagnosis is found should be developed.

Entities:  

Keywords:  Aroma oils; Recurrent fever; South America; Travel

Year:  2015        PMID: 26793454      PMCID: PMC4672615          DOI: 10.1016/j.idcr.2015.03.002

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Introduction

Fever in returning travelers is a common problem and usually the diagnosis is made within a few days or the traveler recovers [1], [2]. We report here two travelers who presented with fever two weeks after returning from a six week vacation in South America. Over the following 18 months they presented with short attacks of fever, elevated CRP and leukocytosis and the program for investigation became more and more elaborate. A curious and key feature was, that they were completely synchronous both developing symptoms within an hour and presentation with the same laboratory findings of leukocytosis and elevated CRP. Extensive and repeated tests were performed. After about a year it turned out that the couple used aroma oils (Nature and Decouvertes – Fig. 1) in the home applied by a nebulizer placed in the middle of a table. The use of the oil matched perfectly with the fever attacks. The oils were not used during summer, also explaining the absence of symptoms during the summer months.
Fig. 1

Aroma oils used by the patients.

Aromatic oils have been used for centuries as healing and soothing scents. Since the use of the oils ended there has been no relapse in any symptoms. It has not been possible to test them with exposure for ethical reasons. We are not aware of or have found any previous reports, in English or other languages, reporting similar events after the use of similar products.

Case presentation

After traveling to South America for a six weeks tourist holiday the two patients returned home to Denmark. Ten days after returning they were both admitted to hospital with fever, muscle and joint pains and vomiting. From the 8 September 2012 to the 22 October 2012 they spent 3 weeks in Peru, half a week in Bolivia, half a week in Chile and 2 weeks in Brazil. They traveled by local busses, stayed at medium level hotels and were not ill at any time during their travels. Prior to their travels they had received vaccines against hepatitis A and B, yellow fever and tetanus/diphtheria. Table 1 shows the patients’ history and Table 2 lists CRP, white blood cell count and recorded rectal temperatures. Day 0 is defined as the first day the couple was admitted to hospital, 10 days after the return from South America. There was no eosinophilia at any given time and the total IgE remained normal throughout.
Table 1

Symptom history.

DaySymptoms
0Fever, joint and muscle pain
10Vomiting, headache, muscle pain, fever
20Night sweats, shivering, headache, light respiratory pain
112Fever, night sweats, shivering, muscle and joint pain, slight non-productive cough
127Muscle and joint pain
136Fever, night sweats, shivering, headache
139Fever, muscle and joint pain
412Fever, muscle and joint pain
434Fever, chest pain, dyspnea, tiredness
Table 2

Biochemical infectious markers.

DayPatient A
Patient B
Temperature (°C)CRP (mg/l)WBC (10*9/l)Temperature (°C)CRP (mg/l)WBC (10*9/l)
037.55832.237.767.234.9
319.96.526.16.7
1037.136.62537.240.624.8
1226.88.2
13115.3
2414.60.96.2
404.46.3<0.65.9
11226.318.25922.7
1196.8524.45.5
1275.715.822.418.5
12924.36.448.35.5
153<0.68.1
166<0.67.7
1941.24.8
196175
39544.51760.218.5
4120.67.6
43437.120.52415.918.6
43538.110.8
Approximately nine episodes occurred within the following 18 months, all attacks being identical in symptoms, duration and paraclinical results for both patients (Table 2). Initially the patients were tested negative for malaria and dengue fever. Under the suspicion of a rickettsial infection they were treated with doxycycline 100 mg two times daily initially for one week [3]. This was immediately afterwards repeated again for one week. After the third relapse, Day 20, the patients received 3 months Doxycycline 100 mg two times daily plus moxifloxacin 400 mg × 1, as it was believed they previously had had a good effect. The patients went through an elaborate program of serological tests and test for nucleic acids of different pathogens, which is summarized in Table 3. Through the whole course a wide range of tests were performed including heart echocardiography, PET-CT and an MRI which were all normal.
Table 3

Test results.

DayTestResult
Patient APatient B
12Borellia burgdorferi (IgM + IgG)NegativeNegative
Bartonella henseale and B. quintana (IgM + IgG)NegativeNegative
Ehrlichia (IgG)PositiveNegative
Francisella tularensisNegativeNegative
Rickettsian rickettsii, R. typhi (IgM + IgG)NegativeNegative
Leptospira (patoc, icterohaemorrhagiae, interro. Copenhageni, canicola, interro. Autumnalis, Hardjo, Pomona, Bataviae, Borgpeters. Tarassovi, Borgpeters. Ballum, Broomii)NegativeNegative
Brucella melitensis and B. abortusNegativeNegative
40Bartonella henselae and B. quintanaNegativeNegative
112Francisella tularensisNegativeNegative
Borellia burgdorferi (IgM + IgG)NegativeNegative
Rickettsia DNANegativeNegative
Rickettsian rickettsii and R. typhi (IgM + IgG)Positive IgM for R. rickettsiiNegative
Bacterial DNA (PCR)NegativeNegative
Ehrlichia (IgG)PositiveNegative
Bartonella henselae, B. quintana, B. bacilliformis*NegativeNegative
Coxiella burnetii (IgM + IgG phase I and II)InconclusiveNegative
Rickettsia conorii, R. felis, R. typhi*NegativeNegative
Bartonella PCR*NegativeNegative
Brucella melitensis, B. abortusNegativeNegative
129Bacterial DNA (PCR)NegativeNegative
164Mayaro Virus RNA**NegativeNegative
Borrelia burgdorferi**NegativeNegative
Chikungunya Virus**NegativeNegative
Rickettsia**NegativeNegative
188Oropouche Virus**NegativeNegative
196Leishmaniasis + Trypanosoma cruzi antibodiesNegativeNegative
395Bacterial DNA (PCR) + Parasite DNA (PCR)NegativeNegative
Bartonelle henselae (IgM + IgG), B. quintana (IgM + IgG)NegativeNegative
434RickettsiaNegativeNegative
Bacterial DNA (PCR)NegativeNegative
Trypanosoma cruzi, Trypanosoma brucei gambiense, T. brucei rhodensienseNegativeNegative
Leishmania antibodiesNegativeNegative
Coxiella burnetti (Q-fever) antibodiesNegativeNegative

Tested at Unité Des Rickettsies, France.

Tested at Porton Down, UK.

Discussion

Definition of travel associated disease “is a patient who has crossed an international boarder within the past 10 years and presents for a presumed travel-related disease” [4]. It is not uncommon for travelers to report an illness associated with their travels (20–70%), but only a small portion of these actually seek medical attention [2], [5], [6]. A detailed medical history is a very important tool in correct diagnosis, including destinations, risk factors, previous medical history. Incubation time is also important to keep in mind through the process (Table 5) [2], [5], [7].
Table 5

Incubation period.

DiseaseIncubation time
Dengue fever3–14 days
Leptospirosis4–14 days
Borrelia5–15 days
Francisella1–14 days
Bartonella bacilliformis/Oroya fever1–3 weeks
Rickettsia10–14 days
Malaria8–30 days
Q fever/Coxiella2–3 weeks
Brucella2–4 weeks
SyphilisPrimary 3–90 days
Chagas disease/Trypanosoma cruziAcute: immediate, chronic: >8 weeks
Leishmaniasis>1 week
Epstein Barr virus
HIV
Tuberculosis
Cytomegalovirus
The GeoSentinel surveillance program has found that the most common causes of fever after traveling is malaria, dengue fever, enteric fever (Salmonella typhi) and rickettsioses [2]. Initially malaria and dengue fever were excluded and the patients were treated with doxycycline under the presumption of a rickettsia or bartonella infection. When the fever attacks continued we excluded endocarditis due to Coxiella burnetii (Q fever) and looked for South American trypanosomiasis due to Trypanosoma cruzi (Chagas disease), which can be transmitted orally through fresh fruit juice. We speculated that Toxoplasma gondii was a possibility as T. gondii genotypes in South America are more pathogenic compared to Europe [8], but only one of the subjects had antibodies at a low titer, not compatible with an acute infection. Leptospirosis was also a diagnostic option, especially with a second phase of fever shortly after the first; this was however also excluded by a negative serology. Acute schistosomiasis and other parasites were ruled out as there was no eosinophilia or elevated total-IgE in either patient. Different centers were asked to assist with this case, including Unité Des Rickettsies, France, Porton Down, UK and Center for Disease Control and Prevention (CDC), United States. See Table 3, Table 4 for list of all the test and results found on the patients. Everything that was tested for came out negative, including blood and urine cultures.
Table 4

Laboratory results from Aarhus University Hospital, Denmark.

DayTestResult
Patient APatient B
0Microscopy for malariaNegativeNegative
0Dengue rapid testNegativeNegative
0Blood cultures × 4NegativeNegative
10Microscopy for malaria and Borrelia recurrentisNegativeNegative
10Blood cultures × 2NegativeNegative
11Microscopy for malaria and B. recurrentisNegativeNegative
12Microscopy for malaria and B. recurrentisNegativeNegative
112Blood cultures × 2NegativeNegative
112Cervical swabNegative
112Swap for Chlamydia + gonococci PCR and cultureNegative
119Microscopy for malariaNegativeNegative
127Blood cultures × 2NegativeNegative
129Toxoplasma gondii IgM + IgGNegativePositive (IgG 85 UI/ml)
129Mycobacterium tuberculosis interferon release assayNegativeNegative
129Blood cultures × 2NegativeNegative
129HIV antibody and antigen testNegativeNegative
129SyphilisNegativeNegative
129EBV serologyPrevious infection (EBNA IgG positive)Negative
129CMV serologyPrevious infection (IgG positive)Negative
304HIV antibody and antigen testNegative
304HAV, HBV; HCVNegative
395HIVNegativeNegative
395Toxoplasma gondii IgM + IgGNegativePositive (IgG 92 UI/ml)
412Swap for Chlamydia DNA + Gonococci cultureNegative
434Mycobacterium tuberculosisNegativeNegative
434HIV antibody and antigen testNegative
434Toxoplasma gondii IgM + IgGNegativePositive (IgG 84 UI/ml)
435Urine cultureNegative
435Blood culture × 2Negative
440HIV (routine test in pregnancy)Negative
440Syphilis (routine test in pregnancy)Negative
Cytomegalovirus and Epstein–Barr virus were also considered as they are a common cause to fever of unknown origin in adults [9]. HIV and other sexually transmitted diseases were also screened for and these results were also negative. The patients were not tested for histoplasmosis as this rarely causes a prolonged course of disease in immunocompetent patients [10]. Throughout the long period of symptoms with this couple it became more and more apparent that it was not an infectious agent at play. Their symptoms and blood test were too synchronized. The attacks were short lived and the CRP and leukocytosis normalized within a few days. Malignancy and inflammatory diseases were also ruled out as the cause of the recurrent fever. Both patients had a slight dry cough and small, non-tender, lymph glands at several stations. There was no rash. One would expect the patients to react differently to the same infectious agent as their immune systems are different as they differ genetically. We, therefore, started searching for an agent they could both be exposed to in the home. All the symptoms seemed to occur during autumn, winter and spring – during which the windows are closed. It is therefore believed to be repeated exposure to aroma oils (Nature and Decouvertes) that is the cause of the symptoms. Since the exposure has stopped there have been no more events. For ethical reasons it has not been possible to test with expose. The story emphasizes that natural products are not inherently safe. The oils used here were nebulized and we assume that the two patients inhaled a high concentration of the nebulized oils over a short time. This was actually recommended by the manufacturer and the oils and table top nebulizer was purchased together. As mentioned earlier, we are not aware of reports of any similar events after using other similar products. The investigational program was build up over time as new attacks continued to occur and suggestions from different centers which were consulted were followed up. The number of tests performed at different laboratories took time and emphasizes that a panel of analysis in returning travelers with continued symptoms but without a clear diagnosis should be developed.

Conflicts of interest

None declared.

Patient consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
  9 in total

Review 1.  Fever in the returning traveler, part one: A methodological approach to initial evaluation.

Authors:  Michael David Schwartz
Journal:  Wilderness Environ Med       Date:  2003       Impact factor: 1.518

Review 2.  Fever in the returning traveler, part II: A methodological approach to initial management.

Authors:  Michael David Schwartz
Journal:  Wilderness Environ Med       Date:  2003       Impact factor: 1.518

3.  The epidemiology of tick-borne relapsing fever in the United States.

Authors:  Mark S Dworkin; Phyllis C Shoemaker; Curtis L Fritz; Mark E Dowell; Donald E Anderson
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

Review 4.  Travel-related infections.

Authors:  Hans R House; Jesmin P Ehlers
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

5.  Diagnostic dilemma in a returning traveler with fever.

Authors:  Jelena Catania; Seth S Martin; G Ralph Corey; Daniel S Sexton
Journal:  Diagn Microbiol Infect Dis       Date:  2013-07-18       Impact factor: 2.803

6.  Spectrum of disease and relation to place of exposure among ill returned travelers.

Authors:  David O Freedman; Leisa H Weld; Phyllis E Kozarsky; Tamara Fisk; Rachel Robins; Frank von Sonnenburg; Jay S Keystone; Prativa Pandey; Martin S Cetron
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

7.  Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.

Authors:  Kira Harvey; Douglas H Esposito; Pauline Han; Phyllis Kozarsky; David O Freedman; D Adam Plier; Mark J Sotir
Journal:  MMWR Surveill Summ       Date:  2013-07-19

Review 8.  Genetic diversity of Toxoplasma gondii in animals and humans.

Authors:  L David Sibley; Asis Khan; James W Ajioka; Benjamin M Rosenthal
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

Review 9.  Fever in the returning traveler.

Authors:  Simon Kotlyar; Brian T Rice
Journal:  Emerg Med Clin North Am       Date:  2013-09-18       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.